Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open-label and randomized placebo-controlled trials

Arthritis and Rheumatism

Volumn 43, Issue 11, 2000, Pages 2383-2390

  Charles, P J ^a   Smeenk, R J T ^b   De Jong, J ^b   Feldmann, M ^a   Maini, R N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN M; INFLIXIMAB; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOFLUORESCENCE; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DNA; FEMALE; HUMANS; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; RANDOMIZED CONTROLLED TRIALS; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033763979     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D     Document Type: Article

References (39)

1. Drug induced lupus
2. Serologic evaluation of patients receiving procainamide
3. Follow-up of patients with double stranded DNA antibodies induced by sulphasalazine during the treatment of inflammatory rheumatic diseases
4. Induction of systemic lupus erythematosus by interferon-γ in a patient with rheumatoid arthritis
5. Autoimmunity after alphainterferon therapy for malignant carcinoid tumors
6. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a
7. TNFα: A pivotal role in rheumatoid arthritis?
8. Monoclonal anti-TNFα antibody as a probe of pathogenesis and therapy of rheumatoid disease
9. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
10. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor (cA2) versus placebo in rheumatoid arthritis
11. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis
12. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
13. Infliximab (chimeric anti-tumor necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
14. Determination of anti-dsDNA antibodies by three different methods: Comparison of sensitivity, specificity, and correlation with lupus activity index (LAI)
15. An immunofluorescent method using Crithidia luciliae to detect antibodies to double-stranded DNA
16. Comparison of three techniques for the detection of antibodies to double stranded DNA: Immunofluorescence on Trypanosome gambiense, immunofluorescence on Crithidia luciliae and radioimmunoassay using the Farr technique
17. The Crithidia luciliae test in the diagnosis of systemic lupus erythaematosus
18. Nature of double-stranded DNA binding activity in seropositive rheumatoid arthritis: Formation of low avidity DNA/rheumatoid factor/low density lipoprotein complexes
19. Characteristics of antibodies adsorbed on the DNA immunoadsorbent, agarose poly-L-lysine-DNA
20. Detection of antibodies to double stranded DNA and extractable nuclear antigen
21. Measurement of antibodies to DNA
22. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
23. Detection of antibodies to DNA: A technical assessment
24. Subnucleosome structures as substrates in enzyme linked immunosorbent assays
25. IgG and IgM antibodies in systemic lupus erythematosus
26. Correlation of serum IgG, IgM, and anti-native-DNA antibodies with renal and clinical indexes of activity in systemic lupus erythematosus
27. Natural autoantibodies
28. Natural autoantibodies in the serum of healthy women - A five-year followup
29. Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies
30. Avidity of antibodies in SLE: Relation to severity of renal involvement
31. Avidity of antibodies to dsDNA: Comparison of IFT on Crithidia Luciliae, Farr assay and PEG assay
32. Stability of DNA/anti-DNA complexes. II. Salt liability and avidity
33. dsDNA antibodies
34. A review of the serological abnormalities in the relatives of patients with systemic lupus erythaematosus
35. Detection of cross-reactive anti-DNA antibody idiotypes in the serum of systemic lupus erythematosus patients and of their relatives
36. Autoantigens targeted in systemic lupus erythaematosus are clustered in two populations of surface structures on apoptotic keratinocytes
37. Structure and function of pentaxins
38. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity